Why Biohaven (BHVN) Shares Are Sliding in Pre‑Market Trading Biohaven's Balancing Act: Cash Cushion Grows, But So Does the Dilution Shadow The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets Biohaven Investors Alert: Opportunity to Lead Securities Fraud Lawsuit Over Alleged Misrepresentations